Co-Diagnostics Inc (CODX)

$0.25 -0.01 (-4.02%)
Market Cap 8.33M
Revenue (ttm) 3.92M
Net Income (ttm) -37.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -960.20%
Debt to Equity Ratio 0.00
Volume 1,055,200
Avg Vol 864,688
Day's Range N/A - N/A
Shares Out 33.57M
Stochastic %K 19%
Beta 0.51
Analysts Sell
Price Target $5.50

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices
Sector: Healthcare
Phone: (801) 438-1036
Website: co-dx.com
Address:
2401 S. Foothill Dr., Suite D, Salt Lake City, United States
Antiquarian
Antiquarian Aug. 2 at 9:45 PM
$CODX
0 · Reply
Goosem4n
Goosem4n Aug. 2 at 2:01 PM
$CODX this stock was big during COVID but now that the pandemic is gone, what's left exactly except a stock losing money and trading lower and lower ? Anyone know what they're up to that could turn the ship around other than COVID? (Please mention specific pipelines)
1 · Reply
Antiquarian
Antiquarian Aug. 2 at 2:20 AM
$CODX
0 · Reply
Minutiae
Minutiae Aug. 1 at 10:15 PM
$CODX Aug 1 CODX short volume 45% out of a 1,045,635 trade volume closing at $0.2482. FINRA Short Sales Volume 319,584 shorted shares out of 712,738. 3,473 after-hour shares traded at $0.2425 to $0.2509 so far. Why is Co-Dx continuing to sell shares at this ridiculously low price??? Can't they hold off and choose days to sell when Trunp is not destroying the stock market? Use some common sense!!!
1 · Reply
Antiquarian
Antiquarian Aug. 1 at 7:59 PM
$CODX
0 · Reply
Minutiae
Minutiae Aug. 1 at 6:18 PM
$CODX COVID-19 National Wastewater Data - Jul 31, 2025 https://www.cdc.gov/nwss/rv/COVID19-national-data.html
0 · Reply
Love1010
Love1010 Aug. 1 at 2:57 PM
$CODX Reverse split is guaranteed. I give it a 100% probability. No catalyst in the next year.
0 · Reply
PattyBergeron
PattyBergeron Aug. 1 at 2:54 PM
$CODX so....is R/S a threat here. What's the clock on non compliance?
1 · Reply
diamondhope
diamondhope Aug. 1 at 2:46 PM
$CODX te
0 · Reply
Sisar
Sisar Aug. 1 at 2:45 PM
$CODX do you know if this will be delisted?
1 · Reply
Latest News on CODX
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 31, 2025, 9:30 AM EDT - 2 days ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Jul 15, 2025, 9:30 AM EDT - 18 days ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 14, 2025, 9:30 AM EDT - 2 months ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:59 PM EDT - 3 months ago

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 3 months ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Apr 29, 2025, 7:30 AM EDT - 3 months ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 6:44 PM EDT - 4 months ago

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 27, 2025, 4:01 PM EDT - 4 months ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 13, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Mar 3, 2025, 9:30 AM EST - 5 months ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Feb 24, 2025, 8:18 AM EST - 5 months ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Feb 21, 2025, 4:00 PM EST - 5 months ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Jan 7, 2025, 9:30 AM EST - 7 months ago

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Dec 10, 2024, 9:30 AM EST - 8 months ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 8:49 PM EST - 9 months ago

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:01 PM EST - 9 months ago

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Nov 5, 2024, 9:30 AM EST - 9 months ago

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Oct 25, 2024, 4:01 PM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

Oct 21, 2024, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3

Oct 2, 2024, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Sep 24, 2024, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

Sep 5, 2024, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

Aug 15, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:14 AM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago

Jul 29, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Jul 25, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

Jul 2, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Jun 18, 2024, 1:30 PM EDT - 1 year ago

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Jun 14, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript

May 9, 2024, 9:30 PM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

May 9, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

Apr 25, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan

Apr 24, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event

Apr 12, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Apr 4, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Mar 21, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England

Mar 18, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England

Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 9:19 PM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results

Mar 14, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

Mar 7, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast

Feb 29, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024

Feb 1, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Dec 27, 2023, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Nov 29, 2023, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:59 PM EST - 1 year ago

Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:01 PM EST - 1 year ago

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

Nov 2, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Oct 31, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

Oct 26, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

Antiquarian
Antiquarian Aug. 2 at 9:45 PM
$CODX
0 · Reply
Goosem4n
Goosem4n Aug. 2 at 2:01 PM
$CODX this stock was big during COVID but now that the pandemic is gone, what's left exactly except a stock losing money and trading lower and lower ? Anyone know what they're up to that could turn the ship around other than COVID? (Please mention specific pipelines)
1 · Reply
Antiquarian
Antiquarian Aug. 2 at 2:20 AM
$CODX
0 · Reply
Minutiae
Minutiae Aug. 1 at 10:15 PM
$CODX Aug 1 CODX short volume 45% out of a 1,045,635 trade volume closing at $0.2482. FINRA Short Sales Volume 319,584 shorted shares out of 712,738. 3,473 after-hour shares traded at $0.2425 to $0.2509 so far. Why is Co-Dx continuing to sell shares at this ridiculously low price??? Can't they hold off and choose days to sell when Trunp is not destroying the stock market? Use some common sense!!!
1 · Reply
Antiquarian
Antiquarian Aug. 1 at 7:59 PM
$CODX
0 · Reply
Minutiae
Minutiae Aug. 1 at 6:18 PM
$CODX COVID-19 National Wastewater Data - Jul 31, 2025 https://www.cdc.gov/nwss/rv/COVID19-national-data.html
0 · Reply
Love1010
Love1010 Aug. 1 at 2:57 PM
$CODX Reverse split is guaranteed. I give it a 100% probability. No catalyst in the next year.
0 · Reply
PattyBergeron
PattyBergeron Aug. 1 at 2:54 PM
$CODX so....is R/S a threat here. What's the clock on non compliance?
1 · Reply
diamondhope
diamondhope Aug. 1 at 2:46 PM
$CODX te
0 · Reply
Sisar
Sisar Aug. 1 at 2:45 PM
$CODX do you know if this will be delisted?
1 · Reply
diamondhope
diamondhope Aug. 1 at 2:42 PM
$CODX tyvm; What does over the air capability bring to the user? Not familiar with the term in our context.
1 · Reply
Minutiae
Minutiae Jul. 31 at 10:25 PM
$CODX Jul 31 CODX short volume 43% out of a 580,297 trade volume closing at $0.2586. FINRA Short Sales Volume 181,913 shorted shares out of 426,338. 16,418 after-hour shares traded at $0.25 to $0.2625 so far. At least CODX closed up today. Most of the market closed down.
0 · Reply
Millones
Millones Jul. 31 at 6:10 PM
$CODX Bovine Tuberculosis UK, North Carolina Tuberculosis USA https://www.yahoo.com/news/articles/tuberculosis-case-identified-avery-county-001127763.html https://www.radiotimes.com/tv/entertainment/jeremy-clarkson-diddly-squat-farm-tuberculosis-newsupdate/
2 · Reply
Millones
Millones Jul. 31 at 6:08 PM
$CODX TB is caused by Mycobacterium tuberculosis, a bacterium that spreads from person to person through water droplets. Having access to clean water, sanitation, and hygiene products greatly reduces people’s exposure. That is one reason why rates tend to be higher in lower-income countries. Many people have “latent tuberculosis”, which means they have been infected with the bacterium but it’s inactive in their system: they don’t have any symptoms, and they can’t spread the disease.2 In this case, the bacteria are effectively surrounded by granulomas — small clusters of immune cells — that stop them from multiplying and keep them suppressed. But when someone’s immune system weakens or is compromised, the bacteria can break out of these granulomas and multiply. That person then has “active tuberculosis”, which means they are contagious and develop TB symptoms. https://ourworldindata.org/ending-tuberculosis-save-millions
1 · Reply
Dany_italy
Dany_italy Jul. 31 at 5:24 PM
$CODX What do you think Mr. codx will say at the August 14 conference? Usual bullshit or something concrete? Here for now everything is dead unfortunately
3 · Reply
Sisar
Sisar Jul. 31 at 2:55 PM
$CODX do you know until which day it will be in nasdaq... i don't want the same happens to me as Vaxart that went to OTC and now i can not sell the stocks
2 · Reply
Millones
Millones Jul. 31 at 2:50 PM
$CODX No splits, only natural organic decline. Wowza
2 · Reply
Millones
Millones Jul. 31 at 2:32 PM
$CODX 4 for $1.00 ✅
1 · Reply
Millones
Millones Jul. 31 at 2:03 PM
$CODX “Co-Dx was founded on our passion for bringing high-quality molecular diagnostics to areas in the world that have been overlooked and underserved by other diagnostics companies. Since 2013, we have been guided by our vision of lowering the cost of healthcare by increasing access to gold-standard PCR tools. Using our patented Co-Primers™ technology, proprietary development platform, and years of experience, we were the first US-based company to receive a CE-marking for a COVID-19 test in early 2020, as we worked to help slow the spread of the pandemic through our global network of distributors covering clinical labs in more than 50 countries.”
0 · Reply
Minutiae
Minutiae Jul. 31 at 1:45 PM
$CODX Looks like Co-Dx is using a different Webcast service for the Q2 2025 Earnings Call this time around. Register here: https://app.webinar.net/wOmnbrGlJa7
1 · Reply
Millones
Millones Jul. 31 at 1:33 PM
$CODX 🚨 Earnings press release 🚨 https://ir.co-dx.com/2025-07-31-Co-Diagnostics,-Inc-Announces-Second-Quarter-2025-Earnings-Release-Date-and-Webcast SALT LAKE CITY, July 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
1 · Reply
bobleeswagger1
bobleeswagger1 Jul. 31 at 1:32 PM
$CODX expecting a little more a of a pullback down to .24 then on the road back up
0 · Reply